JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

Search

LifeStance Health Group Inc

Slēgts

SektorsVeselības aprūpe

4.94 0.61

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

4.75

Max

4.96

Galvenie mērījumi

By Trading Economics

Ienākumi

-4.5M

-3.8M

Pārdošana

12M

345M

Peļņas marža

-1.098

Darbinieki

7,708

EBITDA

1.8M

11M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+83.67% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 6. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

471M

2B

Iepriekšējā atvēršanas cena

4.33

Iepriekšējā slēgšanas cena

4.94

Ziņu noskaņojums

By Acuity

50%

50%

142 / 373 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bearish Evidence

LifeStance Health Group Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 3. nov. 21:44 UTC

Peļņas

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

2025. g. 3. nov. 23:44 UTC

Tirgus saruna

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

2025. g. 3. nov. 23:34 UTC

Tirgus saruna

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

2025. g. 3. nov. 23:28 UTC

Peļņas

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

2025. g. 3. nov. 23:24 UTC

Peļņas

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

2025. g. 3. nov. 23:14 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Global Equities Roundup: Market Talk

2025. g. 3. nov. 23:14 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

2025. g. 3. nov. 23:12 UTC

Peļņas

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

2025. g. 3. nov. 23:09 UTC

Peļņas

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

2025. g. 3. nov. 23:09 UTC

Peļņas

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

2025. g. 3. nov. 23:09 UTC

Peļņas

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

2025. g. 3. nov. 23:06 UTC

Tirgus saruna
Peļņas

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

2025. g. 3. nov. 22:36 UTC

Tirgus saruna
Peļņas

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

2025. g. 3. nov. 22:31 UTC

Peļņas

Franco-Nevada 3Q EPS $1.49 >FNV

2025. g. 3. nov. 22:31 UTC

Peļņas

Franco-Nevada 3Q Rev $487.7M >FNV

2025. g. 3. nov. 22:24 UTC

Tirgus saruna

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

2025. g. 3. nov. 22:19 UTC

Iegādes, apvienošanās, pārņemšana

Starbucks Agrees to Sell Stake in China Business -- WSJ

2025. g. 3. nov. 21:59 UTC

Tirgus saruna

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

2025. g. 3. nov. 21:54 UTC

Tirgus saruna
Peļņas

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

2025. g. 3. nov. 21:54 UTC

Tirgus saruna
Peļņas

Global Equities Roundup: Market Talk

2025. g. 3. nov. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 3. nov. 21:49 UTC

Peļņas

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

2025. g. 3. nov. 21:40 UTC

Peļņas

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

2025. g. 3. nov. 21:31 UTC

Tirgus saruna

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

2025. g. 3. nov. 21:19 UTC

Peļņas

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

2025. g. 3. nov. 21:11 UTC

Iegādes, apvienošanās, pārņemšana

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

2025. g. 3. nov. 21:11 UTC

Peļņas

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

2025. g. 3. nov. 21:07 UTC

Peļņas

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

2025. g. 3. nov. 21:05 UTC

Peļņas

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

2025. g. 3. nov. 21:05 UTC

Peļņas

Palantir Technologies 3Q Net $475.6M >PLTR

Salīdzinājums

Cenas izmaiņa

LifeStance Health Group Inc Prognoze

Cenas mērķis

By TipRanks

83.67% augšup

Prognoze 12 mēnešiem

Vidējais 9 USD  83.67%

Augstākais 10 USD

Zemākais 8 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi LifeStance Health Group Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

4 ratings

4

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

5.39 / 6.595Atbalsts un pretestība

Īstermiņā

Strong Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

142 / 373 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par LifeStance Health Group Inc

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
help-icon Live chat